Anidulafungin
Anidulafungin.JPG

Anidulafungin

CLINICAL USE

Antifungal agent: Invasive candidiasis

DOSE IN NORMAL RENAL FUNCTION

200 mg loading dose then 100 mg daily Oesophageal candidiasis: 100 mg loading dose then 50 mg daily

PHARMACOKINETICS

  • Molecular weight                           : 1140.2
  • %Protein binding                           : >99
  • %Excreted unchanged in urine     : <1
  • Volume of distribution (L/kg)       : 30–50 litres
  • half-life – normal/ESRD (hrs)      : 40–50/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                : Not dialysed. Dose as in normal renal function
  • HD                     : Not dialysed. Dose as in normal renal function
  • HDF/high flux   : Unlikely to be dialysed. Dose as in normal renal function
  • CAV/VVHD      : Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs None known

    ADMINISTRATION

    Reconstition

    With diluent provided

    Route

    IV infusion

    Rate of Administration

    1.1 mg/minute (3 mL/minute)

    Comments

    Can be further diluted in sodium chloride 0.9% or glucose 5%. Add 100 mg to 250 mL or 200 mg to 500 mL of fluid



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs